Lotus Eye Hospital and Institute Limited

NSE:LOTUSEYE.NS

69.89 (INR) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 482.099470.439380.862316.668399.81379.788375.041339.647311.322298.98286.945291.084262.257191.409141.686116.765107.356
Cost of Revenue 364.703219.848188.239156.529189.492181.793178.462167.802144.903151.89179.68884.84484.89728.31943.17223.93621.423
Gross Profit 117.396250.591192.623160.139210.318197.995196.579171.845166.419147.089207.257206.24177.36163.0998.51492.82985.933
Gross Profit Ratio 0.2440.5330.5060.5060.5260.5210.5240.5060.5350.4920.7220.7090.6760.8520.6950.7950.8
Reseach & Development Expenses 0.5360.4880.8310.4980000000000000
General & Administrative Expenses 76.59120.5285.1665.2116.6788.3259.7538.3429.19226.5889.6857.69400000
Selling & Marketing Expenses 12.7813.4679.8973.3112.77711.5688.1214.8511.3784.2134.7086.54500000
SG&A 89.37133.99515.0638.52119.45519.89317.87413.19310.5730.80140.92237.16600000
Other Expenses 13.02711.4554.3583.5154.5735.1235.2423.528155.376169.766208.907203.607198.513155.27993.74369.27353.693
Operating Expenses 89.371204.531158.289144.858194.764193.351182.742173.141165.946169.766208.907203.607198.513155.27993.74369.27353.693
Operating Income 28.02550.3236.43314.316.1834.64413.837-1.2960.473-22.677-1.652.633-21.1537.8114.77123.55632.24
Operating Income Ratio 0.0580.1070.0960.0450.040.0120.037-0.0040.002-0.076-0.0060.009-0.0810.0410.0340.2020.3
Total Other Income Expenses Net 12.1126.2014.5035.623-1.6281.6353.1875.313-0.6780.4342.6481.911-0.487-1.037-5.186-8.337-8.636
Income Before Tax 40.13756.52140.93619.92214.5556.27917.0244.017-0.205-22.2430.9984.544-21.646.774-0.41515.21923.604
Income Before Tax Ratio 0.0830.120.1070.0630.0360.0170.0450.012-0.001-0.0740.0030.016-0.0830.035-0.0030.130.22
Income Tax Expense 10.99215.74611.0914.2423.909-0.802-0.442-0.257-1.213-2.4350.6080.3940.0662.4231.9733.31410.983
Net Income 29.14540.77529.84515.6810.6467.08117.4674.2741.008-19.8080.394.15-21.7064.351-2.38811.90512.621
Net Income Ratio 0.060.0870.0780.050.0270.0190.0470.0130.003-0.0660.0010.014-0.0830.023-0.0170.1020.118
EPS 1.41.961.440.750.510.340.840.210.05-0.950.020.2-1.040.21-0.110.561.23
EPS Diluted 1.41.961.440.750.510.340.840.210.05-0.950.020.2-1.040.21-0.110.561.23
EBITDA 65.30387.3266.3414347.68840.21454.75639.40346.67925.66836.46642.0418.8334.19630.41840.20442.295
EBITDA Ratio 0.1350.1860.1740.1360.1190.1060.1460.1160.150.0860.1270.1440.0720.1790.2150.3440.394